Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 811

Kyn Therapeutics binds Celgene investment

UT Austin-founded Kyn Therapeutics has been backed by Celgene in a strategic pact that also includes a $80m non-equity payment, giving Celgene the right to license two programs.

Jan 18, 2019

Lime lines up $400m round

The scooter and bicycle rental service, which counts Uber and Alphabet as backers, is reportedly set to raise funding at a $2bn valuation.

Jan 17, 2019

CommonGrounds works up $100m series A

Seed investor Pacifica returned to back the workspace provider in a series A round that will fund its expansion to approximately 50 locations in the next two years.

Jan 17, 2019

Waterloo puts Velocity behind angel fund

University of Waterloo hopes to raise $1.2m to $1.8m for an angel fund to make equity investments in the winners of its Velocity Fund Finals competition.

Jan 17, 2019

UNLV touts Food Genes and Me

Dietary suggestion software spinout Food Genes and Me compiles personalised healthy eating tips based on uploaded DNA reports from external genetic analysis tools.

Jan 17, 2019

Alation aligns with Salesforce to raise $50m

Salesforce Ventures has backed the data cataloguing software producer in a series C round that took its funding to $82m altogether.

Jan 17, 2019

Bringg receives $25m series C delivery

Next47 has joined existing investors including Coca-Cola, Ituran and Salesforce in the round, which increased the logistics software provider's total funding to $53m.

Jan 17, 2019

Trice Medical traverses series C extension

The orthopaedic diagnostics equipment developer has added $18.5m to a series C round featuring Smith & Nephew that now stands at $37.6m.

Jan 17, 2019

Scout RFP procures $33m

Workday Ventures and Salesforce Ventures both contributed to the business procurement management platform's series C round, taking its total funding past $60m.

Jan 17, 2019

Vast Therapeutics inhales $15m

The respiratory disease drug developer has collected series A funding from investors including Shionogi to fund clinical trials of its lead drug candidate .

Jan 17, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here